Iright
BRAND / VENDOR: Biolegend

Biolegend, 100221, APC/Cyanine7 anti-mouse CD3 Antibody, 25μg

CATALOG NUMBER: 100221
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: γδTCR-positive T-T hybridoma D1
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.
Application References(PubMed link indicates BioLegend citation): Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Chung Y, et al. 2014. J Vis Exp. 89: 51660. PubMed Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed Jeon Y, et al. 2022. Cancers (Basel). 14:. PubMed Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed Spitzer D, et al. 2023. Nat Protoc. 18:1510. PubMed Wang YC, et al. 2023. J Exp Med. 220:. PubMed Li G, et al. 2023. Cell Death Dis. 14:185. PubMed Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed Pelletier A, et al. 2023. EMBO Rep. 24:e56156. PubMed Tong L, et al. 2023. Sci Adv. 9:eade5041. PubMed Yazicioglu YF, et al. 2023. Nat Immunol. 24:991. PubMed Zhang J, et al. 2023. Theranostics. 13:2226. PubMed Wang Y, et al. 2023. iScience. 26:106630. PubMed van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed Wu Y, et al. 2021. Immunity. 54:2595. PubMed Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed Lee SH, et al. 2023. Nutrients. 15: . PubMed Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed Tao X, et al. 2022. J Exp Med. 219:. PubMed Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed Israelow B, et al. 2020. bioRxiv. . PubMed Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed Ferrere G, et al. 2021. JCI Insight. 6:. PubMed Durgeau A, et al. 2018. Nat Commun. 9:5097. PubMed Silver AC, et al. 2018. Heliyon. 4:e00579. PubMed Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed Turner JA, et al. 2020. Immunity. 53:1202. PubMed Chen S, et al. 2022. Cancer Discov. :. PubMed Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed Diao L, et al. 2022. iScience. 25:105511. PubMed Tirado-Gonzalez I, et al. 2021. Cancer Discov. 11:2924. PubMed Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed Mathews J, et al. 2014. PLoS One. 9:97707. PubMed Shi L, et al. 2021. Immunity. . PubMed Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed Inoue D, et al. 2021. Nat Genet. 53:707. PubMed Chung H, et al. 2021. Immune Netw. 21:e28. PubMed Wang Z, et al. 2020. Autophagy. 1:. PubMed Spees A, et al. 2014. Infect Immun . 82:1692. PubMed Yoshimi A, et al. 2019. Nature. 574:273. PubMed Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed Katsinas N, et al. 2022. J Clin Med. 11:. PubMed Xue L, et al. 2021. BMC Cancer. 21:1134. PubMed Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed Socodato R, et al. 2020. Sci Signal. 13: . PubMed Adane B, et al. 2019. Cell Rep. 27:238. PubMed Rashidi M, et al. 2019. J Immunol. 203:736. PubMed Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed Liu X, et al. 2022. Nat Cancer. :. PubMed Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed Alameh MG, et al. 2021. Immunity. 54:2877. PubMed Li X, et al. 2020. Nat Commun. 4.877777778. PubMed Voss M, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L188 - L195. PubMed Lang V, et al. 2021. Elife. 10:. PubMed Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed Zhu W, et al. 2019. FASEB J. 33:5208. PubMed Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed Kwok T, et al. 2022. Front Aging. 3:838943. PubMed Miyauchi E, et al. 2020. Nature. 585:102. PubMed Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed Teater M, et al. 2018. Nat Commun. 9:222. PubMed Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed Dhar P, et al. 2021. Commun Biol. 4:905. PubMed Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed Chen C, et al. 2020. Cell Rep. 2136:30. PubMed Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed Jie Z, et al. 2014. J Immunol. 192:3289. PubMed Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed Wen J, et al. 2015. J Pharmacol Sci. 128: 116-124. PubMed Luo H, et al. 2019. Cell Rep. 26:945. PubMed Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed Wang K, et al. 2021. Nat Commun. 12:4558. PubMed Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
RRID: AB_2057374 (BioLegend Cat. No. 100221) AB_2242784 (BioLegend Cat. No. 100222)
Structure: Ig superfamily, CD3/TCR, 20 kD
Distribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells
Function: Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor: Peptide antigen/MHC-complex
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.
Gene ID: 12502
UniProt: View information about CD3 on UniProt.org
Clone: 17A2
Regulatory Status: RUO
Other Names: T cell antigen receptor complex, T3
Isotype: Rat IgG2b, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924